The blockade of IL‐22 in the chronic HBV mouse model resulted in reduced Th17 recruitment, which was associated with increased progression of liver inflammation.5 While it is unclear whether other immune cells were affected by the blockade of IL‐22 in this study, reduced Th17 could have driven increased inflammation due to impaired clearance of infection. The gene discussed is IL22; the disease is inflammation.